bioRxivBiophysics
Intracellular Optical Doppler Phenotypes of Chemosensitivity in Human Epithelial Ovarian Cancer
Z. Li, D. Nolte, J. Turek, D. Matei, W. Swetzig, N. Nwani, R. An
Abstract
Development of an assay to predict response to chemotherapy has remained an elusive goal in cancer research. We report a phenotypic chemosensitivity assay for epithelial ovarian cancer based on Doppler spectroscopy of infrared light scattered from intracellular motions in living three-dimensional tumor biopsy tissue measured in vitro. The study analyzed biospecimens from 20 human patients with epithelial ovarian cancer. Matched primary and metastatic tumor tissues were collected for 3 patients, and an additional 3 patients provided only metastatic tissues. Doppler fluctuation spectra were obtained using full-field optical coherence tomography through off-axis digital holography. Frequencies in the range from 10 mHz to 10 Hz are sensitive to changes in intracellular dynamics caused by platinum-based chemotherapy. Metastatic tumor tissues were found to display a biodynamic phenotype that was similar to primary tissue from patients who had poor clinical outcomes. The biodynamic phenotypic profile correctly classified 90% [88% to 91% c.i.] of the patients when the metastatic samples were characterized as having a chemoresistant phenotype. This work suggests that Doppler profiling of tissue response to chemotherapy has the potential to predict patient clinical outcomes based on primary, but not metastatic, tumor tissue.
- organism: human
- assay: imaging
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Patient-Derived Organoids Functionally Stratify Epithelial Ovarian Cancer into Clinically Relevant Chemotherapy Response Phenotypes
Shruthi Ragothaman, Raghuveer Reddy, … Smitha P.K.·bioRxiv·Jul 7, 2026
- Ovarian cancer-on-chip for patient-specific profiling of treatment responses to sequential chemotherapy and PD-L1 blockade
Sarah Plöger, Nicole Anderle, … Peter Loskill·bioRxiv·Jul 24, 2026
- Label-free visualization and quantification of the drug-type-dependent response of tumor spheroids by dynamic optical coherence tomography
I. Abd El-Sadek, R. Morishita, … Y. Yasuno·bioRxiv·Sep 28, 2023
- Chemophototherapy Overcomes Doxorubicin Resistance in Human Ovarian Cancer Cells
S. Ghosh, U. Chitgupi, … J. Lovell·bioRxiv·Feb 14, 2022
- Predicting response to cytotoxic chemotherapy
J. Thompson, L. Madrid, … G. Macintyre·bioRxiv·Jan 28, 2023
- Organoid Models Derived from Primary Tumors and Patient-Derive Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer Patients
Parisa Nikeghbal, Dorsa Zamanian, … Mara P. Steinkamp·BMC CancerPeer-reviewed·Sep 30, 2025